Background and objective
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a well-established treatment for various haematologic and oncologic disorders, yet its clinical success is frequently compromised by complications such as pulmonary graft-versus-host disease (GvHD). Spirometry is the gold standard for monitoring and diagnosis, but it is insensitive to small airway changes. Oscillometry may complement spirometry as a way of detecting change in small airway function. This study assessed the longitudinal change and variability in spirometry and oscillometry following allo-HSCT and predictors of this change.
Methods
Longitudinal spirometry and oscillometry were retrospectively obtained from all patients (n = 374) who underwent allo-HSCT at Royal North Shore Hospital in Sydney, Australia, between January 2015 and December 2023.
Results
Baseline post allo-HSCT assessments showed significantly lower FEV1 and FVC in the allo-HSCT group compared to controls. Over the follow-up period, oscillometric indices displayed significant worsening of Rrs5 and Xrs5, whereas FEV1 did not significantly change. Severe cGvHD was associated with a modest decline in FEV1/FVC and Xrs5 trajectory. Notably, a subset of patients demonstrated discordant changes between spirometry and oscillometry, suggesting that oscillometry may capture early small airway dysfunction not evident on traditional spirometric measures.
Conclusion
These findings underscore the potential of oscillometry as a complementary tool in the routine monitoring of lung function post-allo-HSCT. By detecting subtle changes in small airway mechanics, oscillometry could facilitate earlier identification and intervention in patients at risk for developing pulmonary cGvHD, thereby improving long-term clinical outcomes.
扫码关注我们
求助内容:
应助结果提醒方式:
